Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs ketamine on sphincter of Oddi tone during ERCP
IRCT20230817059177N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine and ketamine (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Change in sphincter of Oddi tone during ERCP. Started Sep 2023; status: completed.
02
Drugs
dexmedetomidineketamine
Beyond the preview
Go deeper on IRCT20230817059177N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230817059177N1.